Lombard Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVARF research report →
About the company
Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United States, United Kingdom, Germany, Japan, and other international regions.
- CEO
- Kurt Lemvigh
- IPO
- 2014
- Employees
- 113
- HQ
- Didcot, GB
Price Chart
- Market Cap
- $2.79K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.41
- Div Yield
- 0.00%
- Gross Margin
- 7.85%
- Op Margin
- -241.06%
- Net Margin
- -255.03%
- ROE
- -108.73%
- ROIC
- -45.19%
- Revenue
- $12.17M · -19.49%
- Net Income
- $-31,035,000 · 17.91%
- EPS
- $-1.54 · 27.70%
- Op Income
- $-29,335,000
- FCF YoY
- 24.67%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.81
- Avg Volume
- 111.344
Get TickerSpark's AI analysis on EVARF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EVARF coverage
Recent articles, reports, and earnings notes.
No research on EVARF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EVARF report →Similar companies
Peers in the same neighborhood.